Nandhu Sobhana

Company: Takeda Pharmaceutical Co. Ltd.

Job title: Head of Cell Therapy Innovation IND Engine


The Development of Vδ1 Gamma Delta T cell Platforms For Use In Next-Generation Allogeneic CAR Therapies 3:30 pm

Harnessing the potential of γδ T cells for immunotherapy in solid and hematological malignancies Investigating the advancements of allogeneic Vδ1 γδ T cell therapy platforms Preclinical update on the progress of cell therapy programs utilizing Vδ1 γδ T cellsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.